COLUMBUS, Ohio - The State Medical Board of Ohio is expected to soon evaluate whether to expand the list of conditions for medical marijuana to include cachexia, also known as wasting syndrome.

The burden of cancer cachexia on patients' health-related quality of life, specifically their physical functioning, is well documented, but clinical trials thus far have failed to show meaningful ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...

Cachexia is a condition which denotes the excessive loss of weight. It occurs because of the depletion of adipose tissue and muscle mass in people who are not trying to lose weight. It is also known ...

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

Cachexia is an underappreciated complication of systemic lupus erythematosus, researchers reported. A total of 56.3% of patients developed the involuntary weight loss accompanied by loss of ...

Researchers have discovered a new potential drug target for the lethal wasting disease known as cancer cachexia. Their findings illustrate that even small groups of neurons in the brain can have an ...

Certain cancers cause people to weaken and waste away. A mouse model of this points to tumour-induced blockade of molecules that normally protect muscle innervation and mass. Will the discovery lead ...

Cachexia is clinically obvious in its advanced phase (with gross loss of fat and skeletal muscle), and as such has been recognized as an adverse effect of cancer since the time of Hippocrates. However ...